Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Enrollment status updated to 'No longer looking for participants' indicates the study is no longer enrolling. The update also adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), standardizes the Intervention/Treatment label, and updates the UI version to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:57:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.5.4 to v3.5.5, reflecting a minor update to the page version history. No substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2026-06-05T17:42:20.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page or its underlying system.
    Difference
    0.1%
    Check dated 2026-05-15T05:43:33.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page’s displayed release/version label was updated from Revision v3.5.2 to Revision v3.5.3, indicating a site-level version change rather than a modification to the clinical study record.
    Difference
    0.1%
    Check dated 2026-04-23T22:10:06.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T18:34:37.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added a Medullary thyroid carcinoma topic entry and a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T06:59:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.